You have 9 free searches left this month | for more free features.

Vectibix®

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Vectibix With Chemotherapy for Metastatic Colorectal Cancer

Completed
  • Wild-type RAS Metastatic Colorectal Cancer
  • Panitumumab + Chemotherapy
  • (no location specified)
Nov 4, 2022

New Prognostic Score for Adult RAS Wild-type mCRC Treated With

Active, not recruiting
  • Metastatic Colorectal Cancer
  • RAS Wild-type
  • Freiburg, Baden-Württemberg, Germany
    Praxis für interdisziplinäre Onkologie & Hämatologie
Jul 29, 2022

Metastatic Colon Cancer Trial in Italy (Trifluridine Tipiracil, Panitumumab 20 MG/1 ML Intravenous Solution [VECTIBIX])

Completed
  • Metastatic Colon Cancer
  • Trifluridine Tipiracil
  • Panitumumab 20 MG/1 ML Intravenous Solution [VECTIBIX]
  • Monserrato, CA, Italy
  • +7 more
Jul 21, 2022

Colorectal Cancer, KRAS Wildtype, NRAS Wildtype Trial in Toronto (Trametinib, Panitumumab)

Completed
  • Colorectal Cancer
  • +3 more
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
May 12, 2022

Colorectal Cancer, Colorectal Tumors, Colorectal Carcinoma Trial in France, United Kingdom, United States (NUC-3373 +

Recruiting
  • Colorectal Cancer
  • +4 more
  • NUC-3373 + leucovorin
  • +8 more
  • Boston, Massachusetts
  • +9 more
Jan 23, 2023

Breast Cancer Trial in Houston (Panitumumab, Nab-paclitaxel, Carboplatin)

Completed
  • Breast Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 20, 2022

Pancreatic Adenocarcinoma Trial in Palo Alto (procedure, biological, drug)

Active, not recruiting
  • Pancreatic Adenocarcinoma
  • Fluorescence Imaging
  • +2 more
  • Palo Alto, California
    Stanford University, School of Medicine
Jun 21, 2022

Describe the Patterns of KRAS Testing and Vectibix Use in Europe

Completed
  • Metastatic Colorectal Cancer
  • Other
  • Bonheiden, Belgium
  • +83 more
Sep 8, 2022

EGFR NP_005219.2:p.S492R, KRAS Gene Mutation, MAP2K1 Gene Mutation Trial in Houston (other, biological, drug)

Recruiting
  • EGFR NP_005219.2:p.S492R
  • +7 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 5, 2022

Metastatic Colorectal Cancer Trial in Eschweiler, Wilhelmshaven (Maintenance Chemotherapy, Panitumumab (Within maintenance

Active, not recruiting
  • Metastatic Colorectal Cancer
  • Maintenance Chemotherapy
  • +3 more
  • Eschweiler, Germany
  • +1 more
Sep 9, 2021

Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor Trial (procedure, biological, drug)

Not yet recruiting
  • Advanced Malignant Solid Neoplasm
  • Metastatic Malignant Solid Neoplasm
  • Biopsy
  • +5 more
  • (no location specified)
Dec 2, 2022

Colorectal Cancer Trial in Milano, Candiolo, Padova (Panitumumab 20 MG/ML Intravenous Solution [VECTIBIX], Molecular Screening)

Active, not recruiting
  • Colorectal Cancer
  • Panitumumab 20 MG/ML Intravenous Solution [VECTIBIX]
  • Molecular Screening
  • Milano, Via Giacomo Venezian, 1, Italy
  • +3 more
Aug 26, 2021

Advanced Microsatellite Stable Colorectal Carcinoma, Metastatic Microsatellite Stable Colorectal Carcinoma, Microsatellite

Recruiting
  • Advanced Microsatellite Stable Colorectal Carcinoma
  • +5 more
  • Atlanta, Georgia
  • +2 more
Oct 29, 2021

Squamous Cell Carcinoma, Adenocarcinoma, Esophageal Cancer Trial in Amsterdam (Carboplatin, Paclitaxel, panitumumab)

Completed
  • Squamous Cell Carcinoma
  • +3 more
  • Amsterdam, Netherlands
    Academic Medical Center
Apr 19, 2021

Colon Cancer Trial in United States (Panitumumab, Nivolumab, Ipilimumab)

Active, not recruiting
  • Colon Cancer
  • Tampa, Florida
  • +4 more
Nov 10, 2021

Healthy Males Trial in Guiyang, Kunming (QL1203, Vectibix®)

Unknown status
  • Healthy Males
  • Guiyang, Guizhou, China
  • +1 more
May 17, 2020

Colorectal Cancer Trial in United States (BBI608, Panitumumab, Capecitabine)

Completed
  • Colorectal Cancer
  • Scottsdale, Arizona
  • +12 more
Apr 4, 2022

Malignant Brain Tumor, Malignant Glioma Trial in Palo Alto (procedure, biological, drug, device)

Suspended
  • Malignant Brain Neoplasm
  • Malignant Glioma
  • Near-Infrared Fluorescence Imaging
  • +3 more
  • Palo Alto, California
    Stanford University School of Medicine
Aug 10, 2021

Rectal Cancer Trial in Spain (Panitumumab, 5Fluorouracil, Oxaliplatin)

Completed
  • Rectal Cancer
  • Elche, Alicante, Spain
  • +10 more
Mar 16, 2022

Colorectal Cancer Trial in Durham (Panitumumab, Cabozantinib)

Completed
  • Colorectal Cancer
  • Durham, North Carolina
    Duke Cancer Center, Duke University Medical Center
Feb 9, 2021

Colorectal Cancer Trial in France (drug, genetic, other)

Completed
  • Colorectal Cancer
  • Angers, France
  • +8 more
Aug 26, 2021

Advanced Colorectal Cancer Trial in Cyprus, Greece (Panitumumab)

Terminated
  • Advanced Colorectal Cancer
  • Strovolos, Nicosia, Cyprus
  • +7 more
Jun 2, 2021

Stage I Breast Cancer AJCC v7, Stage IA Breast Cancer AJCC v7, Stage IB Breast Cancer AJCC v7 Trial in Houston (Carboplatin,

Recruiting
  • Stage I Breast Cancer AJCC v7
  • +10 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 12, 2022

Colorectal Tumor, Colorectal Cancer Trial in Fairfax, Falls Church (Imatinib mesylate and panitumumab, Standard-of-care

Completed
  • Colorectal Neoplasm
  • Colorectal Cancer
  • Imatinib mesylate and panitumumab
  • Standard-of-care treatment with panitumumab
  • Fairfax, Virginia
  • +1 more
Jun 12, 2020

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8

Recruiting
  • Anatomic Stage III Breast Cancer AJCC v8
  • +12 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 16, 2022